Alteration of Fibroblast Architecture and Loss of Basal Lamina Apertures in Human Emphysematous Lung
Overview
Affiliations
Rationale: In normal human lung, single alveolar fibroblasts link capillary endothelium to type 2 pneumocytes through apertures in the endothelial and epithelial basal laminae. These fibroblasts are hypothesized to play a role in cellular communication between the endothelium and epithelium and are positioned to provide leukocytes a surface on which they may migrate through the interstitium.
Objectives: To determine whether fibroblasts link the endothelium to the epithelium in emphysematous lung and to compare basal lamina aperture frequency with previously published results.
Methods: We performed transmission electron microscopy serial section three-dimensional reconstructions of emphysematous regions of human alveolar wall and a quantitative analysis of basal lamina apertures beneath 403 type 2 pneumocytes.
Measurements And Main Results: Our three-dimensional reconstruction demonstrated that the fibroblasts subtending type 2 pneumocytes in emphysematous lung no longer link these epithelial cells to the capillary endothelium through basal lamina apertures. Basal lamina apertures may be absent below some type 2 pneumocytes. Our morphometric analysis showed that their frequency and area beneath type 2 pneumocytes is significantly reduced in emphysematous regions when compared with nonemphysematous regions of matched control lung.
Conclusions: We conclude that the endothelial/fibroblast/epithelial linkage is disrupted in emphysematous human lungs and postulate this disruption may disturb leukocyte migration and account for their accumulation in the alveolar interstitium of emphysematous lung tissue.
Imbalance Between Injury and Defense in the COPD Emphysematous Phenotype.
Bai S, Zhao L Front Med (Lausanne). 2021; 8:653332.
PMID: 34026786 PMC: 8131650. DOI: 10.3389/fmed.2021.653332.
Volume electron microscopy: analyzing the lung.
Schneider J, Hegermann J, Wrede C Histochem Cell Biol. 2020; 155(2):241-260.
PMID: 32944795 PMC: 7910248. DOI: 10.1007/s00418-020-01916-3.
Koo S, Kim S, Choi S, Lee H Tuberc Respir Dis (Seoul). 2019; 82(4):285-297.
PMID: 31172701 PMC: 6778739. DOI: 10.4046/trd.2019.0009.
Correll K, Edeen K, Zemans R, Redente E, Serban K, Curran-Everett D Am J Physiol Lung Cell Mol Physiol. 2019; 317(2):L283-L294.
PMID: 31166130 PMC: 6842887. DOI: 10.1152/ajplung.00337.2018.
New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.
Ding Q, Luckhardt T, Hecker L, Zhou Y, Liu G, Antony V Drugs. 2011; 71(8):981-1001.
PMID: 21668038 PMC: 3955181. DOI: 10.2165/11591490-000000000-00000.